AWM Investment Company’s Benitec Biopharma BNTC Stock Holding History

AWM Investment Company’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2M	Sell	187,977 -95,000	-34%	-$1.1M	0.22%	76
2025 Q4	$3.81M	Buy	282,977 +100,000	+55%	+$1.38M	0.37%	69
2025 Q3	$2.57M	Buy	182,977 +45,000	+33%	+$574K	0.24%	82
2025 Q2	$1.61M	Hold	137,977	–	–	0.18%	81
2025 Q1	$1.8M	Buy	137,977 +35,950	+35%	+$435K	0.25%	74
2024 Q4	$1.29M	Sell	102,027 -522,973	-84%	-$5.65M	0.16%	71
2024 Q3	$5.74M	Hold	625,000	–	–	0.7%	48
2024 Q2	$4.37M	Buy	+625,000	New	+$4.61M	0.59%	52

Other funds holding BNTC

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

AWM Investment Company's BNTC Position: Q1 2026 in Review

AWM Investment Company reduced its Benitec Biopharma (BNTC) stake by 34% in Q1 2026, selling an estimated $1.1M and leaving 187,977 shares worth $2M. The position accounts for 0.22% of the portfolio, ranked #76.

AWM Investment Company first reported a position in BNTC in Q2 2024 and has held it in 8 quarters since. The position peaked at $5.74M in Q3 2024. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

AWM Investment Company held 187,977 shares of Benitec Biopharma worth $2M as of Q1 2026.
AWM Investment Company sold 95,000 Benitec Biopharma shares in Q1 2026, an estimated $1.1M.
Benitec Biopharma made up 0.22% of AWM Investment Company's portfolio in Q1 2026, its #76 holding.
AWM Investment Company first reported a position in Benitec Biopharma in Q2 2024 and has held it in 8 quarters since.
AWM Investment Company's Benitec Biopharma position peaked at $5.74M in Q3 2024.
88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.